LICENSE AGREEMENTLicense Agreement • October 7th, 2016 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • New York
This license agreement including all Schedules hereto (the “Agreement”) is entered into as of the latest date of signature appearing below (the “Effective Date”) by and between UCB Biopharma Sprl, a Belgian corporation with offices located at Allée de la Recherche 60, 1070 Brussels, Belgium (“UCB”) and Syndax Pharmaceuticals, Inc. a Delaware corporation with offices located at 400 Totten Pond Road, Suite 110, Waltham, Massachusetts 02451, USA (“Company”). UCB and Company are from time to time referred to herein individually as a “Party” or collectively as the “Parties”.
